Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer

Medical Oncology ◽

10.1007/s12032-015-0563-5 ◽

2015 ◽

Vol 32 (4) ◽

Author(s):

Dong Xue ◽

Shuyan Han ◽

Shantong Jiang ◽

Hong Sun ◽

Yanzhi Chen ◽

...

Keyword(s):

Lung Cancer ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Comprehensive Geriatric Assessment ◽

Symptom Control ◽

Small Cell Lung

Download Full-text

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793518485 ◽

2016 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Comprehensive Geriatric Assessment ◽

Phase Iii ◽

Small Cell Lung

Download Full-text

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793519511 ◽

2016 ◽

Author(s):

Theodora Karnakis

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Comprehensive Geriatric Assessment ◽

Phase Iii ◽

Small Cell Lung

Download Full-text

A multicenter phase II randomized study of docetaxel (D)/gemcitabine (G) weekly followed by erlotinib (E) after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non-small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA): Groupe Français de Pneumocancerologie (GFPC)*0504.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7536 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7536-7536

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

S. Bota ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Comprehensive Geriatric Assessment ◽

Randomized Study ◽

Small Cell Lung ◽

Multicenter Phase

Download Full-text

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793552776 ◽

2018 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Comprehensive Geriatric Assessment ◽

Phase Iii ◽

Small Cell Lung

Download Full-text

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial

Journal of Integrative Medicine ◽

10.1016/s2095-4964(14)60028-5 ◽

2014 ◽

Vol 12 (3) ◽

pp. 175-181 ◽

Author(s):

Zhi-yi Zhou ◽

Ling Xu ◽

He-gen Li ◽

Jian-hui Tian ◽

Li-jing Jiao ◽

...

Keyword(s):

Lung Cancer ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell Lung ◽

Download Full-text

P66 A multicenter phase II randomized study of docetaxel/gemcitabine weekly followed by erlotinib after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA) (gfpc*0504): preliminary results

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(09)70104-0 ◽

2009 ◽

Vol 72 (1) ◽

pp. S42

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

D. Balas ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Comprehensive Geriatric Assessment ◽

Randomized Study ◽

Small Cell Lung ◽

Multicenter Phase

Download Full-text

A multicenter phase II randomized study of gemcitabine (G) weekly followed by erlotinib (E) after progression versus E followed by G after progression in advanced non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18002 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18002-e18002

Author(s):

H. Jullian ◽

L. Greillier ◽

C. Chouaid ◽

R. Corre ◽

J. Crequit ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Comprehensive Geriatric Assessment ◽

Randomized Study ◽

Small Cell Lung ◽

Multicenter Phase ◽

Vulnerable Elderly

Download Full-text

ESOGIA: a “first step” for comprehensive geriatric assessment-guided treatment in non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2016.07.33 ◽

2016 ◽

Vol 5 (S2) ◽

pp. S371-S373

Author(s):

Romain Corre ◽

Christos Chouaïd

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Comprehensive Geriatric Assessment ◽

Small Cell Lung

Download Full-text

Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells

Journal of Ethnopharmacology ◽

10.1016/j.jep.2018.02.020 ◽

2018 ◽

Vol 217 ◽

pp. 140-151 ◽

Author(s):

Qian Wang ◽

Narayan Acharya ◽

Zhongwei Liu ◽

Xianmei Zhou ◽

Meghan Cromie ◽

...

Keyword(s):

Lung Cancer ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Small Cell Lung Cancer ◽

Cancer Cells ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Scutellaria Barbata ◽

Anticancer Effects

Download Full-text

Intensive management for raising survival rate of small cell lung cancer (SCLC) with combined multi-therapy including traditional Chinese medicine

Lung Cancer ◽

10.1016/s0169-5002(00)80323-2 ◽

2000 ◽

Vol 29 (1) ◽

pp. 98

Author(s):

R Cha ◽

W Li ◽

L Zheng ◽

D Zeng ◽

Wei-Hua Li

Keyword(s):

Lung Cancer ◽

Survival Rate ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Intensive Management ◽

Small Cell Lung

Download Full-text